These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8026608

  • 1. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
    Martignat L, Feve B, Charbonnel B, Sai P.
    Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
    [Abstract] [Full Text] [Related]

  • 2. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P.
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [Abstract] [Full Text] [Related]

  • 3. Proteins spontaneously released by rat insulinoma (RIN) cells are anchored on cell membrane by a glycosyl-phosphatidyl-inositol link and inhibit increased RIN cell adhesion of lymphocytes from type 1 diabetic patients and non-obese diabetic mice in vitro.
    Gouin E, Segain JP, Saï P.
    Diabetes Metab; 1996 Dec; 22(6):439-50. PubMed ID: 8985653
    [Abstract] [Full Text] [Related]

  • 4. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ, French MB, Chosich N, Harrison LC.
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [Abstract] [Full Text] [Related]

  • 5. Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study.
    Timsit J, Debray-Sachs M, Boitard C, Bach JF.
    Clin Exp Immunol; 1988 Aug; 73(2):260-4. PubMed ID: 3052943
    [Abstract] [Full Text] [Related]

  • 6. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
    Peterson JD, Pike B, McDuffie M, Haskins K.
    J Immunol; 1994 Sep 15; 153(6):2800-6. PubMed ID: 8077683
    [Abstract] [Full Text] [Related]

  • 7. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.
    J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677
    [Abstract] [Full Text] [Related]

  • 8. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.
    Cell Immunol; 2005 May 15; 235(1):1-11. PubMed ID: 16122720
    [Abstract] [Full Text] [Related]

  • 9. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
    Füchtenbusch M, Larger E, Thebault K, Boitard C.
    Horm Metab Res; 2005 Feb 15; 37(2):63-7. PubMed ID: 15778920
    [Abstract] [Full Text] [Related]

  • 10. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA.
    J Autoimmun; 1996 Jun 15; 9(3):341-8. PubMed ID: 8816969
    [Abstract] [Full Text] [Related]

  • 11. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M.
    Cell Immunol; 1993 Apr 15; 148(1):189-97. PubMed ID: 8098666
    [Abstract] [Full Text] [Related]

  • 12. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
    Atlan-Gepner C, Hermitte L, Janand-Delenne B, Naquet P, Vialettes B.
    Diabetes Metab; 1997 Nov 15; 23(5):386-94. PubMed ID: 9416430
    [Abstract] [Full Text] [Related]

  • 13. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D, Marcus H, Reshef T, Ablamunits V, Cohen IR.
    Eur J Immunol; 1995 Oct 15; 25(10):2851-7. PubMed ID: 7589082
    [Abstract] [Full Text] [Related]

  • 14. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P.
    Eur J Immunol; 1990 Jun 15; 20(6):1297-303. PubMed ID: 2164479
    [Abstract] [Full Text] [Related]

  • 15. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep 15; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
    Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarui S.
    Clin Exp Immunol; 1985 Jun 15; 60(3):622-30. PubMed ID: 3160515
    [Abstract] [Full Text] [Related]

  • 18. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels.
    Reddy S, Bibby NJ, Elliott RB.
    Diabetes Res; 1990 Oct 15; 15(2):95-102. PubMed ID: 2151892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.